Trevi Therapeutics (TRVI) Other Non Operating Income (2021 - 2025)
Trevi Therapeutics (TRVI) posted quarterly Other Non Operating Income of $30000.0 for Q4 2025, down 96.71% year-over-year from $912000.0 in Q4 2024, and up 1600.0% quarter-over-quarter from -$2000.0 in Q3 2025.
Trevi Therapeutics (TRVI) Other Non Operating Income (2021 - 2025) Analysis & Trends
Trevi Therapeutics' Other Non Operating Income history runs 5 years deep, the most recent figure standing at $30000.0 for Q4 2025.
- In Q4 2025, Other Non Operating Income fell 96.71% year-over-year to $30000.0; the TTM figure through Dec 2025 stood at $933000.0 (up 4.25% YoY), while the FY2025 annual figure was $14000.0, down 98.44% from the prior year.
- Other Non Operating Income for Q4 2025 stood at $30000.0, up from -$2000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $5.5 million in Q4 2022, with the low at -$404000.0 in Q4 2021.
- The 5-year median for Other Non Operating Income is -$2500.0 (2023), against an average of $356111.1.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income plunged 440.0% in 2022, then jumped 30500.0% in 2024.
- Trevi Therapeutics' Other Non Operating Income stood at -$404000.0 in 2021, then soared by 1473.02% to $5.5 million in 2022, then slumped by 100.05% to -$3000.0 in 2023, then surged by 30500.0% to $912000.0 in 2024, then slumped by 96.71% to $30000.0 in 2025.
- Business Quant data shows TRVI's Other Non Operating Income at $30000.0 in Q4 2025, -$2000.0 in Q3 2025, and -$7000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Trevi Therapeutics | 2.63 Bn | 2.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Dec 31, 2024 | 912,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | 154,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Mar 31, 2023 | 165,000.00 |
| Dec 31, 2022 | 5.55 Mn |
| Jun 30, 2022 | -136,000.00 |
| Mar 31, 2022 | -11,000.00 |
| Dec 31, 2021 | -404,000.00 |
| Sep 30, 2021 | -5,000.00 |
| Jun 30, 2021 | 40,000.00 |
| Mar 31, 2021 | -6,000.00 |